Back to Journals » Cancer Management and Research » Volume 9
Original Research
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,514 | Dovepress* | 9,714+ | 1,236 | 10,950 | |
PubMed Central* | 800 | 237 | 1,037 | ||
Totals | 10,514 | 1,473 | 11,987 | ||
*Since 19 May 2017 |
View citations on PubMed Central and Google Scholar